logo
  

Stellantis In Deal With Samsung SDI To Form North American JV To Produce Lithium-Ion Battery

Automaker Stellantis N.V. (STLA) announced Friday that it has entered into a memorandum of understanding with rechargeable battery maker Samsung SDI to form a joint venture to produce lithium-ion battery cells and modules for North America.

The transaction is subject to agreement on definitive documentation and customary closing conditions, including regulatory approvals.

The location of the new facility is currently under review and the companies will share further details at a later date. The new battery plant is targeted to start in 2025. It aims to have an initial annual production capacity of 23 gigawatt hours, with the ability to increase up to 40 gigawatt hours in the future.

Stellantis said it is now well advanced in the process of securing annual production capacity for electric vehicle batteries. This will result in achieving 40% of its sales in the U.S. comprised of electrified vehicles by 2030.

The battery plants will fulfill the needs of Stellantis assembly plants throughout the US, Canada, and Mexico for installation in next-generation electric vehicles.

Stellantis plans to invest more than 30 billion euros through 2025 in electrification and software development.

Young-hyun Jun, President and CEO of Samsung SDI, said, "With this battery joint venture, we will do our best to meet the high standards of our customers in the North American EV market leveraging Samsung SDI's battery technology, high quality products and safety measures."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT